Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R L Comenzo

Showing results (41-50 of 42) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 42 results.
QJM : Monthly Journal of the Association of Physicians|July 15, 2011
Bortezomib in a phase 1 trial for patients with relapsed AL amyloidosis: cardiac responses and overall effectsS W Dubrey, D E Reece, V Sanchorawala, et al.
Leukemia|June 26, 2009
International myeloma working group (IMWG) consensus statement and guidelines regarding the current status of stem cell collection and high-dose therapy for multiple myeloma and the role of plerixafor (AMD 3100)S Giralt, E A Stadtmauer, J L Harousseau, et al.
Pageof 5

Showing results (41-50 of 42) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 42 results.
QJM : Monthly Journal of the Association of Physicians|July 15, 2011
Bortezomib in a phase 1 trial for patients with relapsed AL amyloidosis: cardiac responses and overall effectsS W Dubrey, D E Reece, V Sanchorawala, et al.
Leukemia|June 26, 2009
International myeloma working group (IMWG) consensus statement and guidelines regarding the current status of stem cell collection and high-dose therapy for multiple myeloma and the role of plerixafor (AMD 3100)S Giralt, E A Stadtmauer, J L Harousseau, et al.
Pageof 5